Leena Helle

2.2k total citations
11 papers, 520 citations indexed

About

Leena Helle is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Leena Helle has authored 11 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Leena Helle's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Leena Helle is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Leena Helle collaborates with scholars based in Finland, Sweden and Latvia. Leena Helle's co-authors include Vesa Kataja, Mika Leinonen, Päivi Auvinen, R. Kokko, Petri Bono, Pirkko‐Liisa Kellokumpu‐Lehtinen, Heikki Joensuu, R. Asola, Marjo Pajunen and Jorma Isola and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Leena Helle

10 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leena Helle Finland 7 457 248 155 84 56 11 520
Christopher Stokoe United States 9 480 1.1× 254 1.0× 189 1.2× 134 1.6× 17 0.3× 17 547
Mette S. van Ramshorst Netherlands 11 426 0.9× 384 1.5× 147 0.9× 102 1.2× 31 0.6× 20 586
Antonia Márquez Spain 10 294 0.6× 134 0.5× 71 0.5× 99 1.2× 79 1.4× 15 444
Maeve Waldron-Lynch United States 10 427 0.9× 248 1.0× 95 0.6× 228 2.7× 36 0.6× 21 564
Inge Kemper Netherlands 7 381 0.8× 268 1.1× 94 0.6× 88 1.0× 31 0.6× 11 461
S. Kahlert Germany 6 445 1.0× 299 1.2× 132 0.9× 138 1.6× 10 0.2× 12 539
G. Raab Germany 7 487 1.1× 483 1.9× 67 0.4× 81 1.0× 16 0.3× 19 650
Hannah Douthwaite Spain 6 717 1.6× 428 1.7× 262 1.7× 190 2.3× 47 0.8× 8 835
Rochelle Strenger United States 6 370 0.8× 164 0.7× 131 0.8× 60 0.7× 13 0.2× 19 414
Karen McAdam United Kingdom 11 265 0.6× 124 0.5× 66 0.4× 55 0.7× 12 0.2× 23 343

Countries citing papers authored by Leena Helle

Since Specialization
Citations

This map shows the geographic impact of Leena Helle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leena Helle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leena Helle more than expected).

Fields of papers citing papers by Leena Helle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leena Helle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leena Helle. The network helps show where Leena Helle may publish in the future.

Co-authorship network of co-authors of Leena Helle

This figure shows the co-authorship network connecting the top 25 collaborators of Leena Helle. A scholar is included among the top collaborators of Leena Helle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leena Helle. Leena Helle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Joensuu, Heikki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, et al.. (2013). Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). Acta Oncologica. 53(2). 186–194. 22 indexed citations
2.
Joensuu, Heikki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, et al.. (2011). Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial. Journal of Clinical Oncology. 30(1). 11–18. 76 indexed citations
3.
Joensuu, Heikki, Petri Bono, Vesa Kataja, et al.. (2009). Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial. Journal of Clinical Oncology. 27(34). 5685–5692. 326 indexed citations
4.
Hietanen, T, et al.. (1997). Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer.. PubMed. 11(5 Suppl 4). 37–40. 5 indexed citations
5.
Hietanen, T, et al.. (1996). PP-7-10 A phase II trial on high dose (240 MG) toremifene in the treatment of advanced breast cancer. European Journal of Cancer. 32. 47–47. 1 indexed citations
6.
Liippo, Kari, Leena Helle, Susanna Hinkka‐Yli‐Salomäki, et al.. (1994). Carboplatin and Etoposide in Extensive Small Cell Lung Cancer. Acta Oncologica. 33(8). 921–924. 10 indexed citations
7.
Gröhn, Pentti, et al.. (1994). Combination of carmofur and interferon-alpha-2B in advanced gastrointestinal cancer--a phase II pilot study.. Acta Oncologica. 33(6). 711–3. 1 indexed citations
8.
9.
10.
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Stokoe Breakdown of academic impact, for papers by Mette S. van Ramshorst Breakdown of academic impact, for papers by Antonia Márquez Breakdown of academic impact, for papers by Maeve Waldron-Lynch Breakdown of academic impact, for papers by Inge Kemper Breakdown of academic impact, for papers by S. Kahlert Breakdown of academic impact, for papers by G. Raab Breakdown of academic impact, for papers by Hannah Douthwaite Breakdown of academic impact, for papers by Rochelle Strenger Breakdown of academic impact, for papers by Karen McAdam
Rankless by CCL
2026